Endocrinology
Latest News
Surveillance for 21 Possible Effects of Endocrine Disruptors
French public health agency classified 21 health effects as a priority for surveillance, including metabolic, reproductive effects.
News from the FDA/CDC
Vibrating Belt Receives Approval to Help Women With Osteopenia Keep Bone Strength
The device was the first approved nonpharmacologic treatment for postmenopausal women with low bone density. It has not been tested for ability to...
News from the FDA/CDC
Hypocalcemia Risk Warning Added to Osteoporosis Drug
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney...
Latest News
Testosterone Supplements: Overcoming Current Misconceptions
Low testosterone is commonly underdiagnosed and undertreated in France.
From the Journals
Prostate Risks Similar for Testosterone Therapy and Placebo
Uncertainty and concern exist about a link between prostate cancer risk and testosterone levels.
Latest News
EHR Tool Enhances Primary Aldosteronism Screening in Hypertensive Patients
Use of a best-practice advisory embedded in an EHR led to increased rates of screening for PA, particularly among primary care physicians.
Latest News
Direct Measurement of T3 Is Likely Vital, Say Researchers
T3 may be an important test to identify subclinical changes in thyroid function, say researchers.
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Feature
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.
From the Journals
Testosterone Replacement Therapy and Prostate Cancer Risk
New study suggests testosterone replacement therapy does not increase prostate cancer risk in men with hypogonadism.
From the Journals
Paget Disease of the Bone Progression Halted With Genetic Screening, Targeted Treatment
A single infusion of zoledronic acid substantially reduced existing bone lesions and biochemical markers of bone turnover over 7 years.